Combination of Immunosuppressive Agents in Treatment of Steroid-Resistant Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis

References

• Kaysen, G A. Nephrotic syndrome. In Current Therapy in Nephrology and Hypertension; Glassock, R J., Ed.; Mosby-Year Book: St. Louis, 1998; 223–230.
   Google Scholar
• Dember, L M.; Salant, D J. Minimal change disease. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney; Brady, H R., Wilcox, C S., Ed.; WB Saunders: Philadelphia, PA, 1999; 165–177.
   Google Scholar
• Korbet, S M. Primary focal segmental glomerulosclerosis. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney; Brady, H R., Wilcox, C S., Eds.; WB Saunders: Philadelphia, PA, 1999; 178–188.
   Google Scholar
• U.S. Renal Data System, USRDS 1998 Annual Data Report; National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, April 1998; 23–35.
   Google Scholar
• Rich, A R. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull. John Hopkins Hosp. 1957, 100, 173–183. [CSA]
   PubMedGoogle Scholar
• Habib, R. Focal glomerular sclerosis. Kidney Int. 1973, 4, 355–361. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tejani, A. A morphological transition in minimal change nephrotic syndrome. Nephron 1985, 39, 157–159. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Broyer, M.; Meyrier, A.; Niaudet, P.; , et al. Minimal changes and focal segmental glomerulosclerosis. In Oxford Textbook of Clinical Nephrology, 2nd Ed.; Davison, A M., Cameron, S., Grunfield, J P., et al., Eds.; Oxford University Press: Oxford, 1997; 493–536.
   Google Scholar
• Meyrier, A. Minimal change disease and focal segmental glomerulosclerosis. In The Treatment of Glomerulonephritis; Pusey, C D., Ed.; Kluwer Academic Publishers, 1999; 39–54.
   Google Scholar
• El-Reshaid, K.; Amer, E.; Madda, J P.; Kapoor, M. Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome. Ren. Fail. 1995, 17, 695–703. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Loeffler, K.; Gowrishankar, M.; Tiu, V. Tacrolimus therapy in pediatric patients with treatment-resistant nephritic syndrome. Pediatr. Nephrol. 2004, 19, 281–287. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Niaudet, P.; Broyer, M.; Habib, R. Serial renal biopsies in children with idiopathic nephrosis receiving cyclosporine. In Cyclosporin in the Therapy of Renal Disease; Tejani, A., Ed.; Karger: Basel, 1995; 78–83.
   Google Scholar
• Melcoton, T L.; Kamil, E S.; Cohen, A H.; Fine, R N. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependant nephrotic syndrome. Am. J. Kidney Dis. 1991, 18, 583–588. [CSA]
   PubMedGoogle Scholar
• Niaudet, P.; Habib, R. Cyclosporine in treatment of idiopathic nephrosis. J. Am. Soc. Nephrol. 1994, 5, 1049–1056. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Aradhye, S.; Turka, L A. Immunosuppressive therapy in immunologic renal disease and transplantation. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney; Brady, H R., Wilcox, C S., Eds.; WB Saunders: Philadelphia, PA, 1999; 81–88.
   Google Scholar
• Gellermann, J.; Querfeld, U. Frequently relapsing nephritic syndrome: treatment with mycophenolate mofetil. Pediatr. Nephrol. 2004, 19 (1), 101–104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shapiro, R.; Scantlebury, V P.; Jordan, M L.; , et al. Tacrolimus in pediatric renal transplantation. Transplantation 1996, 62 (12), 1752–1758. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Virji, M.; Carter, J E.; Lirenman, D S. Single-center experience with mycophenolate mofetil in pediatric renal transplant recipients. Pediatr. Transplant. 2001, 5 (4), 293–296. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Mendoza, S A.; Reznik, M V.; Griswold, R W.; Krensky, M A.; Yorgin, P D.; Tune, M B. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr. Nephrol. 1990, 4, 303–307. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mitwalli, A H. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis? Nephrol. Dial. Transplant. 1988, 13, 1524–1528. [CSA], [CROSSREF]
   Google Scholar
• Dantal, J.; Bigot, E.; Bogers, W.; , et al. Effects of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N. Engl. J. Med. 1994, 300, 7–14. [CSA], [CROSSREF]
   Google Scholar
• Chung, J.; Kuo, C J.; Crabtree, G R. Rapamycin-FKBP specifically blocks growth dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992, 69, 1227–1236. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Klipple, J H. Cyclophosphamide: ovarian and other toxicities. Lupus 1995, 4, 1–2. [CSA]
   Google Scholar
• Meyrier, A.; Noel, L H.; Auriche, P.; Callard, P. Long-term renal tolerance to cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int. 1994, 45, 1446–1456. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bolton, W K.; Abdel-Rahman, E. Pathogenesis of focal glomerulosclerosis. Nephron 2001, 88, 6–13. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Frishberg, Y.; Toledano, H.; Becker-Cohen, R.; Feigin, E.; Halle, D. Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis. Am. J. Kidney Dis. 2000, 36, 1253–1261. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Futrakul, N.; Butthep, P.; Patumraj, S.; Tipprukmas, N.; Futrrakul, P. Enhanced tumor necrosis factor in the serum and renal hypoperfusion in nephrosis associated with focal segmental glomerulosclerosis. Ren. Fail. 2000, 22, 213–217. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Briggs, W A.; Gimenez, L F.; Samaniego-Picota, M.; Choi, M J.; Nadasdy, T.; Eustace, J.; Scheel, P J., Jr. Relationship between lymphocyte and clinical steroid responsiveness in focal segmental glomerulosclerosis. J. Clin. Pharmacol. 2000, 40, 115–123. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Alexopoulos, E.; Stangou, M.; Papagianni, A.; Papadimitriou, M. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2000, 15, 1348–1356. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schwartz, M M. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Ren. Fail. 2000, 22, 663–684. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sharma, R.; Sharma, M.; McCarthy, E T.; Ge, X L.; Savin, V J. Components of normal serum block the FSGS factors activity in vitro. Kidney Int. 2000, 58, 1973–1979. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Houck, K A.; Ferrara, N.; Winer, J.; , et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 1991, 5, 1806–1814. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• ISKDC (International Study of Kidney Disease in Children). Ten years of activity: a report for the International Study of Kidney Disease in Children. In Glomerulnephritis; Batsforrd, S R.,, et al., Eds.; John Wiley & Sons: New York, 1977; 201–209.
   Google Scholar
• Meyrier, A.; Simon, P. Treatment of corticoresistant idiopathic nephrotic syndrome in adults: minimal change disease and focal segmental glomerulosclerosis. Adv. Nephrol. 1988, 17, 127–150. [CSA]
   PubMedGoogle Scholar
• Pie, Y.; Cattran, D.; Delmore, T.; Katz, A.; Lang, A.; Rance, P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am. J. Med. 1987, 82, 938–944., [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Niaudet, P.; French Society of Pediatric Nephrology. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J. Pediatr. 1994, 125, 981–986. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Norona, B.; Valentin, M.; Gutierrez, E.; Praga, M. Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil. Nefrologia 2004, 24, 79–82. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Abbott, K C.; Sawyer, E S.; Oliver, J D.; III; Kop, C W.; Kirk, A D.; Welch, P G.; , et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am. J. Kidney Dis. 2001, 37, 366–373. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar